|
Scientist / Sr. Scientist, Pharmaceutical R&D
Alkermes, Inc
|
Waltham, Massachusetts
PURPOSE: To support early translation of discovery compounds and concepts for preclinical studies using approaches based on fundamentals in materials with a focus on nano-sized pharmaceutical materials. The successful candidate will play an active r
|
May-16-2013
|
Pharmaceutical Sales Specialist - CV_SPEC1 - Boston W, MA
AstraZeneca
|
Boston, Massachusetts
: The Hospital Sales Specialist will have primary focus on key Brand academic centers, affiliated institutions and some large community hospitals. MAJOR RESPONSIBILITIES: * Responsible for selling, maintaining and documenting all sales activities for
|
May-16-2013
|
Peptide Sales - Active Pharmaceutical Ingredients, Labs, Pharma
CyberCoders
|
Boston, Massachusetts
Peptide Sales - Active Pharmaceutical Ingredients, Labs, Pharma Peptide Sales - Skills Required - Scientific Field Sales, Peptides, Active Pharmaceutical Ingredients, Fine Chemicals If you are a Sales Representative with Peptide or other Active Pharm
|
May-16-2013
|
Boston, MA Pharmaceutical Sales Representative
inVentiv Health
|
Boston, Massachusetts
. Or, if you know of someone else who might be interested, please send this job to a friend by clicking on the Tell a Friend option at the bottom of this page. City Boston State Massachusetts [MA] Country United States [US] Title Boston, MA Pharmaceu
|
May-16-2013
|
AD, Drug Safety
Biogen Idec
|
Cambridge, Massachusetts
Responsibilities include: * Medical review, assessing company causality, and adjudication of postmarketing and/or clinical trial adverse event reports. * Authoring analyses of similar events. * Ensuring adequacy of recording, summarization, and hand
|
May-16-2013
|
AD, Drug Safety
Biogen Idec
|
Cambridge, Massachusetts
Responsible for medical review of clinical trial adverse event reports and providing strategic safety support to clinical development programs from Phase 1 onwards (including regulatory filings, responses to regulatory authorities, signal evaluation
|
May-16-2013
|